287 related articles for article (PubMed ID: 8443032)
1. Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
Wallén NH; Larsson PT; Bröijersén A; Andersson A; Hjemdahl P
Br J Clin Pharmacol; 1993 Feb; 35(2):143-51. PubMed ID: 8443032
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris.
Wallén NH; Andersson A; Hjemdahl P
Br J Clin Pharmacol; 1994 Jul; 38(1):63-70. PubMed ID: 7946939
[TBL] [Abstract][Full Text] [Related]
3. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
[TBL] [Abstract][Full Text] [Related]
4. Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry.
Larsson PT; Hjemdahl P; Olsson G; Egberg N; Hornstra G
Clin Sci (Lond); 1989 Apr; 76(4):369-76. PubMed ID: 2523769
[TBL] [Abstract][Full Text] [Related]
5. Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements.
Larsson PT; Wallén NH; Egberg N; Hjemdahl P
Clin Sci (Lond); 1992 Apr; 82(4):369-76. PubMed ID: 1315646
[TBL] [Abstract][Full Text] [Related]
6. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
Larsson PT; Wallén NH; Martinsson A; Egberg N; Hjemdahl P
Thromb Haemost; 1992 Dec; 68(6):687-93. PubMed ID: 1337630
[TBL] [Abstract][Full Text] [Related]
7. Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.
Larsson PT; Olsson G; Angelin B; Granström E; Hansson G; Hjemdahl P
Eur J Clin Pharmacol; 1992; 42(4):413-21. PubMed ID: 1387607
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet function by injectable isosorbide dinitrate.
De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
Am J Cardiol; 1984 Jun; 53(11):1683-7. PubMed ID: 6428211
[TBL] [Abstract][Full Text] [Related]
9. [Thrombocyte aggregation and fibrinolysis in healthy probands treated with molsidomine, isosorbide-5-mononitrate and placebo].
Drummer C; Valta-Seufzer U; Spannagl M; Frey A; Lüdke S; Schramm W; Gerzer R
Z Kardiol; 1991; 80 Suppl 5():43-6. PubMed ID: 1776334
[TBL] [Abstract][Full Text] [Related]
10. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration.
Vogt D; Trenk D; Bonn R; Jähnchen E
Eur J Clin Pharmacol; 1994; 46(4):319-24. PubMed ID: 7957516
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
[TBL] [Abstract][Full Text] [Related]
13. In vitro evidence of an endothelial cell-dependent antiplatelet activity for isosorbide dinitrate, but not for its 2- and 5-mononitrate metabolites.
Rolland PH; Berenger FP; Cano JP
J Pharmacol Exp Ther; 1987 Jan; 240(1):234-40. PubMed ID: 3100769
[TBL] [Abstract][Full Text] [Related]
14. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
16. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
Kogi K; Satoh T
Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregability in humans: contrasting in vivo and in vitro findings during sympatho-adrenal activation and relationship to serum lipids.
Larsson PT; Hjemdahl P; Olsson G; Angelin B; Hornstra G
Eur J Clin Invest; 1990 Aug; 20(4):398-405. PubMed ID: 2121499
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet effects of isosorbide dinitrate in man.
De Caterina R; Giannessi D; Crea F; Chierchia S; Bernini W; Gazzetti P; L'Abbate A
Z Kardiol; 1983; 72 Suppl 3():46-51. PubMed ID: 6666233
[TBL] [Abstract][Full Text] [Related]
19. Plasma disposition and hemodynamic effects of a single oral dose of isosorbide dinitrate in human males and females.
Nakatsu K; Brien JF; Savard G; Toffelmire EB; Abdollah H; Bennett BM; Marks GS
Biopharm Drug Dispos; 1992 Jul; 13(5):357-67. PubMed ID: 1498268
[TBL] [Abstract][Full Text] [Related]
20. Isosorbidedinitrate and SIN-1 as dilators of human coronary arteries and platelet inhibitors.
Bult H; Bosmans JM; Vrints CJ; Herman AG
J Cardiovasc Pharmacol; 1995 Apr; 25(4):572-8. PubMed ID: 7596125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
